Location: New York, NY
CIK: 0001420995 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $655M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 980,596 | $653M | 99.7% | $585.18 | — | TR UNIT | 78462F103 |
| SRZN | SURROZEN INC | 47,930 | $618K | 0.1% | $6.97 | +50.3% | COM | 86889P208 |
| TNYA | TENAYA THERAPEUTICS INC | 291,828 | $473K | 0.1% | $21.49 | -95.3% | COM | 87990A106 |
| QTTB | Q32 BIO INC | 133,903 | $265K | 0.0% | $31.58 | -93.9% | COM | 746964105 |
| RAPT | RAPT THERAPEUTICS INC | 9,172 | $237K | 0.0% | $13.09 | 0.0% | COM | 75382E208 |
| VOR | VOR BIOPHARMA INC | 4,595 | $224K | 0.0% | $40.21 | 0.0% | COM | 929033207 |
| XLO | XILIO THERAPEUTICS INC | 249,635 | $210K | 0.0% | $2.41 | -70.3% | COM | 98422T100 |
| SRZNW | SURROZEN INC | 33,333 | $517 | 0.0% | $1.14 | — | *W EXP 08/01/2 | 86889P117 |